Sangamo Therapeutics, Inc. (SGMO)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 0.4930 |
| Open | 0.4865 |
| Bid | 0.5002 x 300 |
| Ask | 0.5068 x 200 |
| Day's range | 0.4600 - 0.5055 |
| 52-week range | 0.2900 - 1.6700 |
| Volume | |
| Avg. volume | 2,443,722 |
| Market cap | 104.37M |
| Beta (5Y monthly) | 1.35 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.4800 |
| Earnings date | 26 Apr 2024 - 29 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 3.50 |
Business WireSangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
RICHMOND, Calif., April 22, 2024--Sangamo Therapeutics to Present Neurology Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at ASGCT
Simply Wall St.What You Need To Know About The Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Analyst Downgrade Today
One thing we could say about the analysts on Sangamo Therapeutics, Inc. ( NASDAQ:SGMO ) - they aren't optimistic...
Business WireSangamo Therapeutics Announces Pricing of $24.0 Million Registered Direct Offering
RICHMOND, Calif., March 22, 2024--SANGAMO THERAPEUTICS ANNOUNCES PRICING OF $24.0 MILLION REGISTERED DIRECT OFFERING
© 2024 Yahoo. All rights reserved.